Literature DB >> 6266694

Accuracy of diagnosis of coronary artery disease by radionuclide management of left ventricular function during rest and exercise.

R H Jones, P McEwan, G E Newman, S Port, S K Rerych, P M Scholz, M T Upton, C A Peter, E H Austin, K H Leong, R J Gibbons, F R Cobb, R E Coleman, D C Sabiston.   

Abstract

Rest and exercise radionuclide angiocardiographic measurements of left ventricular function were obtained in 496 patients who underwent cardiac catheterization for chest pain. Two hundred forty-eight of these patients also had an exercise treadmill test. An ejection fraction less than 50% was the abnormality of resting left ventricular function that provided the greatest diagnostic information. In patients with normal resting left ventricular function, exercise abnormalities that were optimal for diagnosis of coronary artery disease were an injection fraction at least 6% less than predicted, an increase greater than 20 ml in end-systolic volume and the appearance of an exercise-induced wall motion abnormality. The sensitivity and specificity of the test were lower in patients who were taking propranolol at the time of study and in patients who failed to achieve an adequate exercise end point. In the 387 patients with an optimal study, the test had a sensitivity of 90% and a specificity of 58%. Radionuclide angiocardiography was more sensitive and less specific than the exercise treadmill test. The high degree of sensitivity of the radionuclide test suggests that it is most appropriately applied to patient groups with a high prevalence of disease, including those considered for cardiac catheterization.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6266694     DOI: 10.1161/01.cir.64.3.586

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  38 in total

1.  Does exercise radionuclide angiography still have a role in clinical cardiac assessment?

Authors:  A D Kelion; A P Banning; O J Ormerod
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

Review 2.  Measurement of ventricular function with scintigraphic techniques: part I-imaging hardware, radiopharmaceuticals, and first-pass radionuclide angiography.

Authors:  Kim A Williams
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

3.  First-pass radionuclide angiography.

Authors:  John D Friedman; Daniel S Berman; Salvador Borges-Neto; Sean W Hayes; Lynne L Johnson; Kenneth J Nichols; Robert A Pagnanelli; Steven C Port
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

4.  Assessment of ventricular function with first-pass radionuclide angiography using technetium 99m hexakis-2-methoxyisobutylisonitrile: a European multicentre study.

Authors:  G Bisi; R Sciagrà; U Büll; K E Britton; C Eilles; D Eissner; K Hahn; H Höffken; K Joseph; J H McKillop
Journal:  Eur J Nucl Med       Date:  1991

5.  Nuclear medicine: multiple-gated equilibrium radionuclide ventriculography to assess heart function.

Authors:  M Grover-McKay; H R Schelbert
Journal:  West J Med       Date:  1986-02

6.  Assessment of poststress left ventricular ejection fraction by gated SPECT: comparison with equilibrium radionuclide angiocardiography.

Authors:  Wanda Acampa; Maria Grazia Caprio; Emanuele Nicolai; Raffaele Liuzzi; Serena De Luca; Enza Capasso; Luca Luongo; Mario Petretta; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-01       Impact factor: 9.236

7.  Evaluation of a multicrystal gamma camera and rotating chair for tomographic studies of the heart.

Authors:  M K O'Connor; J Koss; C Caiati; R L Morin; T F Christian; R J Gibbons
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

8.  Simultaneous perfusion/function imaging.

Authors:  D S Berman; G Germano; H Kiat; J Friedman
Journal:  J Nucl Cardiol       Date:  1995 May-Jun       Impact factor: 5.952

9.  The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated (82)Rb PET myocardial perfusion imaging.

Authors:  Andrew Van Tosh; John R Votaw; Nathaniel Reichek; Christopher J Palestro; Kenneth J Nichols
Journal:  J Nucl Cardiol       Date:  2013-10-04       Impact factor: 5.952

10.  Exercise testing without interruption of medication for refining the selection of mildly symptomatic patients for prognostic coronary angiography.

Authors:  R Lim; I Kreidieh; L Dyke; J Thomas; D S Dymond
Journal:  Br Heart J       Date:  1994-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.